Oddo BHF maintains its 'outperform' rating on Vivendi shares, with a price target lowered from 13.8 to 13.5 euros.

While Vivendi will publish its quarterly results on October 19, the analyst anticipates slight group-wide sales growth for Q3 (+1.3%), after +4.2% in Q2 and +3.3% in Q1.

We don't expect any strategic changes on the back of these results", says Oddo BHF, which does, however, point out that its 2023 EPS has been "adjusted slightly downwards", due to an update in Multichoice's results.

The analyst believes it will be interesting to follow the company's message on a possible disposal of its UMG shares (10% of the capital) and possibly a resumption of share buybacks.

"Even if it still seems to us that Bolloré should ultimately increase its exposure to Vivendi, we do not expect any decision in the very short term", adds the broker.


Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.